Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) FCF Margin (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed FCF Margin for 2 consecutive years, with 26.34% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 8126.0% to 26.34% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 65.8% through Dec 2025, down 459.0% year-over-year, with the annual reading at 65.8% for FY2025, 459.0% down from the prior year.
  • FCF Margin for Q4 2025 was 26.34% at Day One Biopharmaceuticals, down from 15.39% in the prior quarter.
  • The five-year high for FCF Margin was 53.36% in Q3 2024, with the low at 600.04% in Q2 2024.